Blog

Bosentan 62.5mg Tablets for Pulmonary Arterial Hypertension – INTRABON

• 13-03-2026

Pulmonary Arterial Hypertension (PAH) is a serious cardiovascular condition characterized by increased blood pressure in the arteries of the lungs. This condition makes it harder for the heart to pump blood through the lungs, which may lead to symptoms such as shortness of breath, fatigue, chest pain, dizziness, and reduced physical activity.

INTRABON Tablets contain Bosentan 62.5 mg, an endothelin receptor antagonist that helps reduce pulmonary arterial pressure by relaxing and widening the blood vessels in the lungs. This targeted therapy helps improve blood flow and enhances exercise capacity in patients with pulmonary arterial hypertension.

Composition of INTRABON Tablets

• Bosentan 62.5 mg

Bosentan works by blocking endothelin receptors that cause narrowing of blood vessels, thereby helping improve circulation in the lungs.

How Bosentan 62.5 mg Works

Bosentan inhibits the effects of endothelin-1, a natural chemical that causes blood vessels to constrict.

By blocking endothelin receptors, Bosentan helps:

• Relax pulmonary blood vessels

• Reduce pressure in pulmonary arteries

• Improve oxygen circulation

• Enhance exercise tolerance in PAH patients

This mechanism supports better heart and lung function.

Indications

INTRABON (Bosentan 62.5 mg) Tablets are indicated for:

• Treatment of Pulmonary Arterial Hypertension (PAH)

• Improving exercise capacity in patients with PAH

• Managing symptoms such as breathlessness and fatigue associated with pulmonary hypertension

Key Benefits of INTRABON Tablets

• Helps reduce pulmonary artery pressure

• Improves blood flow in lung circulation

• Enhances exercise capacity

• Helps reduce symptoms of pulmonary hypertension

• Supports better quality of life for PAH patients

Who Can Benefit from INTRABON Tablets?

This medication may be prescribed for:

• Patients diagnosed with pulmonary arterial hypertension

• Individuals experiencing shortness of breath and fatigue due to PAH

• Patients requiring targeted pulmonary hypertension therapy

Dosage and Administration

Dosage:
Take INTRABON Tablets exactly as prescribed by your healthcare professional.

Directions for Use:

• Swallow the tablet with water

• Take at the same time each day for better results

• Do not alter the dose without medical advice

Regular medical monitoring may be required during treatment.

Packing Details

• Composition: Bosentan 62.5 mg

• Packing: 10 × 1 × 10

• Dosage Form: Tablet

Possible Side Effects

Some patients may experience mild side effects, including:

• Headache

• Nasal congestion

• Flushing

• Swelling of legs or ankles

• Changes in liver enzyme levels (monitoring recommended)

Consult your healthcare professional if any symptoms persist.

Conclusion

INTRABON Tablets (Bosentan 62.5 mg) offer targeted treatment for pulmonary arterial hypertension by relaxing blood vessels in the lungs and improving blood circulation. This helps reduce pulmonary pressure, enhance exercise capacity, and improve the overall quality of life for patients living with PAH.

For safe and effective treatment, always take this medication under medical supervision.